THE VASCULAR SOCIETY
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net deficit of £123,046 for the year ended 30 June 2025, reversing a previous decline in Annual Scientific Meeting profits. Per the trustees' report, unrestricted free reserves stood at £790,372, which exceeds the stated policy target of £600,000, providing a buffer against the loss of previous industry funding sources.
What the accounts disclose
“the desirable reserve for the above objectives has been calculated as £600,000”
“The charity has a wholly owned trading subsidiary which is incorporated in the United Kingdom, VSGBI Limited (registered number 04020415)” — page 8
Structured financials (annual return, FY ending 30/06/2025)
Trustees
- Andrew Roger Alleyn Thompson
- Anselm Asehasem Egun
- Christopher Paul Twine
- Colin Bicknell
- Daniel Carradice
- Dr Sadasivam SELVAKUMAR
- James McCaslin
- Jonathan Ghosh
- Kaji Sritharan
- Keith Gordon Jones
- Marco Luigi Baroni
- Marcus John Brooks
- Patrick Coughlin
- Patrick Neil Thomas Lintott
- Paul William Moxey
- Professor Athanasios Saratzis
- Professor Srinivasa Rao Vallabhaneni
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £590k | £718k |
| 30/06/2024 | £958k | £1.1m |
| 30/06/2023 | £797k | £693k |
| 30/06/2022 | £861k | £681k |
| 30/06/2021 | £307k | £310k |
Common questions
Is THE VASCULAR SOCIETY financially healthy?
The accounts state that the charity reported a net deficit of £123,046 for the year ended 30 June 2025, reversing a previous decline in Annual Scientific Meeting profits. Per the trustees' report, unrestricted free reserves stood at £790,372, which exceeds the stated policy target of £600,000, providing a buffer against the loss of previous industry funding sources. Its FY2025 accounts were independently examined.